Gambaran Penggunaan Obat pada Pasien Rawat Inap Infark Miokard Akut (IMA) di UPT RSUD Nene Mallomo
Abstract
According to WHO in the 2014 journal, as many as 7.2 million (12.2%) deaths occurred due to Acute Myocardial Infarction. Myocardial infarction is the second leading cause of death in developing countries, with a figure of 2.4 million (9.4%) Americans (Hurulean, 2020). The type of research used is descriptive quantitative research method with a retrospective approach, namely to provide an overview of drug use in Patients with Acute Myocardial Infarction (AMI). A total of 15 medical records and prescriptions for patients with Acute Myocardial Infarction (AMI) were used as samples. The results showed that patients with Acute Myocardial Infarction at UPT RSUD Nene Mallomo for the period June - December 2021 from the data of 15 confirmed patients suffering from Acute Myocardial Infarction, the most used antiplatelet aggregation drugs with a percentage of 37.1 (Aspilet tablets as many as 2, Miniaspi as many as 8, Clopidogrel 75 mg tablets as many as 8 and briclot as many as 8), then anticoagulant drugs with a percentage of 18.5 (Diviti 2.5 mg as many as 13), and antianginal drugs or nitrate with a percentage of 12.8 (ISDN 5 mg tablets for 2, Farsorbid 5 mg tablets for 1, Farsorbid 10 mg tablets for 2, Cedocard 10 mg tablets for 3).
Downloads
References
Anggraini, D. (2007). Pola Peresepan Obat Kardiovaskuler Berdasarkan Tinjauan Dosis, Interaksi, Kontraindikasi, Dan Efek Samping Obat Pada Pasien Gagal Jantung Di Instalasi Rawat Inap Rsup Dr. Sardjito Periode Januari - Desember Tahun 2003 Skripsi.
Anonim, 1995, Drug Information for the Health Care Professional, USPDI, 15,h edition, United States Pharmocopeial Convention Inc, USA 164- 165 491- 498,1979-1982.
Ganiswama, S.G., Setiabudy, R., Suyatno, F.D., Purwantyasruti, N 1995 Kedokteran Universitas Indonesia, Gaya Baru, Jakarta, 754-757 Farmakologi dan Terapi, edisi 4, Penerbit Bagian Farmakologi Fakultas Kedokteran Universitas Indonesia, Gaya Baru, Jakarta, 754- 757.
Hasanah, N., Putajaya, F., Kania, L., Ismaya, N. W. A., & Aini, N. N. (2021). Gambaran Penyakit Jantung Berdasarkan Demografi Dan Penggunaan Obat 1. Jurnal Kesehatan, 10(1), 100–111. Https://Doi.Org/10.37048/Kesehatan.V10i1.311.
Hurulean, C. M. (2020). Pengaruh Relaksasi Benson Terhadap Penurunan Nyeri Akut Pasien Infark.
Karim,S Kabo Peter 1996, EKG dan Penanggulangan Beberapa Penyakit Jantung, Penerbit FKUI, Jakarta, 127-153,201.
Kurniawati, T. (2018). Asuhan Keperawatan Pada Klien Infark Miokard Akut (Ima) Dengan Masalah Nyeri Akut. Asuhan Keperawatan Pada Klien Infark Miokard Akut (Ima) Dengan Masalah Nyeri Akut.
Mansjoer,A. TriyantiJC Savitri,R., Warfhani, I.W., 2001, Kapita Selekta Kedokteran, edisi ketiga, FKUI, Penerbit Media Aesculapius, 437-440.
Nabila, P. (2020). Penggolongan Obat, Farmakodinamikaa Dan Farmakokinetika, Indikasi Dan Kontraindikasi Serta Efek Samping Obat. Academia Accelerat Ing The World’s Research, 4–5.
Siagian, R. (2019). Gambaran Profil Peresepan Obat Pada Pasien Penyakit Jantung Rawat Jalan Di Rs. Bhayangkara Medan Risma. Politeknik Kesehatan Medan.
Surya, A. (2014). Kadar Profil Lipid, Gula Darah Sewaktu, Dan Asam Urat Pada Penderita Infark Miokard Akut Yang Di Rawat Di Rsup. Dr. Wahidin Sudirohusodo Periode Januari – Desember 2012. Kadar Profil Lipid, Gula Darah Sewaktu, Dan Asam Urat Pada Penderita Infark Miokard Akut Yang Di Rawat Di Rsup. Dr. Wahidin Sudirohusodo Periode Januari – Desember 2012.
Tjay,T.H & Rahardja,K.,2001, Obat-Obat Penting Khasiat, Penggunaan, dan Efek-efek Sampingnya, edisi V, Gramedia, Jakarta, 519, 525- 531, 549-558, 573-581.
Widowati, I. Kumalasari. (2007). Evaluasi Terapi Obatpada Penanganan Pasien Infark Miokard Akutdi Instalasi Rawatinap Rsud Kota Yogyakarta Tahun 2005.
Wulandari, A. (2010). Profil Penggunaan Obat Pasien Jantung Koroner Di Rawat Inap Rumah Sakit Umum Wirabuana Palu. 30(6), 858–864.
Bila bermanfaat silahkan share artikel ini
Berikan Komentar Anda terhadap artikel Gambaran Penggunaan Obat pada Pasien Rawat Inap Infark Miokard Akut (IMA) di UPT RSUD Nene Mallomo
Pages: 70-74
Copyright (c) 2022 Fadilla Syam, Wasliaty Sirajuddin, Ayu Amriani

This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors who publish with this journal agree to the following terms:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under Creative Commons Attribution 4.0 International License that allows others to share the work with an acknowledgment of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgment of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (Refer to The Effect of Open Access).















